|
PFE's Operating Income Growth by Quarter and Year
Pfizer Inc's Operating Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Operating Income Growth Y/Y▼
|
Operating Income Growth Y/Y▼
|
| PFE Operating Income (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
| IV Quarter |
January |
-
|
3,001.00
|
341.00
|
1,535.00
|
| III Quarter |
October |
-
|
6,142.00
|
3,324.00
|
11,045.00
|
| II Quarter |
July |
-
|
5,611.00
|
3,091.00
|
4,266.00
|
| I Quarter |
April |
9,401.00
|
4,679.00
|
4,105.00
|
4,414.00
|
| FY |
|
9,401.00
|
19,433.00
|
10,861.00
|
21,260.00
|
| PFE Operating Income first quarter 2022 Y/Y Growth Comment |
Pfizer Inc achieved in the first quarter 2022, above Company average Operating Income surge of 100.92% year on year, to $ 9,401.00 millions.
Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Operating Income growth. While Pfizer Inc' s Operating Income doubling of 100.92% ranks overall at the positon no. 237 in the first quarter 2022.
Explain Operating Income growth
|
| PFE Operating Income ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
January |
- |
780.06 % |
-77.79 % |
-33.61 % |
| III Quarter |
October |
- |
84.78 % |
-69.9 % |
193.44 % |
| II Quarter |
July |
- |
81.53 % |
-27.54 % |
7.29 % |
| I Quarter |
April |
100.92 % |
13.98 % |
-7 % |
11.78 % |
| FY |
|
- |
78.92 % |
-48.91 % |
51.85 % |
PFE Operating Income (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
January |
- |
-51.14 % |
-89.74 % |
-86.1 % |
| III Quarter |
October |
- |
9.46 % |
7.54 % |
158.91 % |
| II Quarter |
July |
- |
19.92 % |
-24.7 % |
-3.35 % |
| I Quarter |
April |
213.26 % |
1272.14 % |
167.43 % |
90.92 % |
| FY (Year on Year) |
|
- |
78.92 % |
-48.91 % |
51.85 % |
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 49.34 % |
0.67 % |
-49.17 % |
| (Sep 29 2019) |
|
(Sep. 30, 2015) |
|
|
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 49.34 % |
0.67 % |
-49.17 % |
| (Sep 29 2019) |
|
(Sep. 30, 2015) |
|
| Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Pfizer Inc's Q/Q Operating Income Growth
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 79375 % |
1193.22 % |
-99.9 % |
| (March 31, 2010) |
|
|
| PFE's I. Quarter Q/Q Operating Income Comment |
Pfizer Inc achieved in the I. Quarter 2022 below company average Operating Income doubling of 213.26% quarter on quarter, to $ 9,401.00 millions.
Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Operating Income quarter on quarter growth. While Pfizer Inc's Operating Income growth quarter on quarter, overall rank is 87. |
|
|
|
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 79375 % |
1193.22 % |
-99.9 % |
| (March 31, 2010) |
|
|
| PFE's I. Quarter Q/Q Operating Income Comment |
Pfizer Inc achieved in the I. Quarter 2022 below company average Operating Income doubling of 213.26% quarter on quarter, to $ 9,401.00 millions.
Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Operating Income quarter on quarter growth. While Pfizer Inc's Operating Income growth quarter on quarter, overall rank is 87. |
|
Pfizer Inc's 12 Months Operating Income Growth Year on Year
Operating Income TTM Growth |
12 Months Ending
(Apr 03 2022) |
12 Months Ending
(Dec 31 2021) |
12 Months Ending
(Oct 03 2021) |
12 Months Ending
(Jul 04 2021) |
12 Months Ending
(Apr 04 2021) |
| Cumulative Operating Income 12 Months Ending |
$ 24,155.00 |
$ 19,433.00 |
$ 16,773.00 |
$ 13,955.00 |
$ 11,435.00 |
| Y / Y Operating Income Growth (TTM) |
111.24 % |
78.92 % |
39.14 % |
-29.43 % |
-45.42 % |
| Year on Year Operating Income Growth Overall
Ranking |
# 318 |
# 631 |
# 799 |
# 1848 |
# 1809 |
| Seqeuential Operating Income Change (TTM) |
24.3 % |
15.86 % |
20.19 % |
22.04 % |
5.28 % |
| Seq. Operating Income Growth (TTM) Overall
Ranking |
# 237 |
# 295 |
# 439 |
# 770 |
# 1381 |
| Cumulative Operating Income growth
Comment |
With 111.24% annual Operating Income growth, Pfizer Inc would report a record annual Operating Income surge if the fiscal year would end on Apr 03 2022.
Within the Healthcare sector 24 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 318, from total ranking in previous quarter at 631. |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
49.34 % |
0.67 % |
-49.17 % |
|
|
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
111.24 % |
5.63 % |
-61.59 % |
|
|
|
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 9 |
| Sector |
# 17 |
| S&P 500 |
# 237 |
|
| Cumulative Operating Income growth
Comment |
With 111.24% annual Operating Income growth, Pfizer Inc would report a record annual Operating Income surge if the fiscal year would end on Apr 03 2022.
Within the Healthcare sector 24 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 318, from total ranking in previous quarter at 631. |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
49.34 % |
0.67 % |
-49.17 % |
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
111.24 % |
5.63 % |
-61.59 % |
|
|
|
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 9 |
| Sector |
# 17 |
| S&P 500 |
# 237 |
| Companies with similar Operating Income surge for the quarter ending Apr 03 2022 within Healthcare Sector | Y/Y Change % | Operating Income for the quarter ending Apr 03 2022 | | Pfizer Inc |  100.92% | $ 100.919 millions | | Staar Surgical Co | 62.16% | $ 62.155 millions |
|
